Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Cell-Free DNA for GI therapy personalization

John Strickler, MD, Duke Cancer Center, Durham, NC, discusses a combined analysis from Japan and the United States investigating the use of Cell-Free DNA to detect focal versus non-focal MET amplification in metastatic colorectal cancer patients. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.